ASCO 2013 - Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM) - Dr. Richard Carvajal

Video interview with Dr. Richard Carvajal Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM) at ASCO 2013. Author: oncologyeducation Added: 06/23/2013
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts